Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Gastric Cancer

  Free Subscription


Articles published in Eur J Surg Oncol

Retrieve available abstracts of 151 articles:
HTML format



Single Articles


    September 2024
  1. NAGATA H, Kinoshita T, Komatsu M, Habu T, et al
    Comparison of robotic versus laparoscopic total gastrectomy for gastric cancer: A single-center retrospective cohort study in a Japanese high-volume center.
    Eur J Surg Oncol. 2024;50:108706.
    PubMed     Abstract available


  2. ZHENG H, Zheng H, Wei L, Xue Z, et al
    Risk stratification models incorporating oxidative stress factors to predict survival and recurrence in patients with gastric cancer after radical gastrectomy: A real-world multicenter study.
    Eur J Surg Oncol. 2024;50:108658.
    PubMed     Abstract available


  3. VAN DER BURG SJ, Bleckman RF, van der Sluis PC, Hartgrink HH, et al
    Improvement of perioperative outcomes of gastric gastrointestinal stromal tumour (GIST) resections and the influence of minimal invasive surgery.
    Eur J Surg Oncol. 2024;50:108479.
    PubMed     Abstract available


  4. DUMONT F, Kepenekian V, Passot C, Ezanno-Manasterski AC, et al
    PIPAC in patients with peritoneal metastases from gastrointestinal tract (PIPOX01): An open label, non-comparative phase 1/2 dose escalation and expansion trial.
    Eur J Surg Oncol. 2024;50:108468.
    PubMed     Abstract available


  5. HUANG Z, Huang Y, Huang C, Li P, et al
    Reply to: Chemotherapy benefits in patients with hepatoid adenocarcinoma: A long-term follow-up study on a rare gastric disease.
    Eur J Surg Oncol. 2024;50:108407.
    PubMed    


    August 2024
  6. TAKAHASHI K, Terashima M, Notsu A, Koseki Y, et al
    Surgical treatment for liver metastasis from gastric cancer: A systematic review and meta-analysis of long-term outcomes and prognostic factors.
    Eur J Surg Oncol. 2024;50:108582.
    PubMed     Abstract available


  7. WEI S, Yu S
    Reevaluating surgical margins in gastric cancer: Addressing the impact of close resection margins and BMI classification on prognosis.
    Eur J Surg Oncol. 2024 Aug 6:108574. doi: 10.1016/j.ejso.2024.108574.
    PubMed    


  8. PARK JY, Park KB, Kwon OK
    Reply to: Reevaluating surgical margins in gastric cancer: Addressing the impact of close resection margins and BMI classification on prognosis.
    Eur J Surg Oncol. 2024 Aug 3:108575. doi: 10.1016/j.ejso.2024.108575.
    PubMed    


  9. WANG SL, Zhang FM, Chen CB, Dong QT, et al
    Comparison between AWGC-cachexia and GLIM-malnutrition in patients with gastric cancer.
    Eur J Surg Oncol. 2024;50:108580.
    PubMed     Abstract available


  10. VAN DER SLUIS K, Vollebergh MA, Kodach LL, van Dieren JM, et al
    The clinical implications of staging laparoscopy in the diagnostic workup of gastric cancer patients: A population based study.
    Eur J Surg Oncol. 2024;50:108569.
    PubMed     Abstract available


    July 2024
  11. ITAMI T, Kurokawa Y, Yoshioka R, Saito T, et al
    Measuring serum and drainage fluid interleukin-6 and tumor necrosis factor-alpha levels for early detection of infectious complications after minimally invasive surgery for gastric cancer.
    Eur J Surg Oncol. 2024;50:108564.
    PubMed     Abstract available


  12. HERRERA KOK JH, Marano L, van den Berg JW, Shetty P, et al
    Current trends in the management of Gastro-oEsophageal cancers: Updates to the ESSO core curriculum (ESSO-ETC-UGI-WG initiative).
    Eur J Surg Oncol. 2024;50:108387.
    PubMed     Abstract available


  13. ALEMDAR A, Duman MG, Sengiz Erhan S, Sasako M, et al
    Histopathologic response in patients with curative resection with D2 dissection following neoadjuvant treatment for locally advanced gastric and esophagogastric junction adenocarcinoma.
    Eur J Surg Oncol. 2024;50:108428.
    PubMed     Abstract available


    June 2024
  14. PARK JY, Yang JY, Park KB, Kwon OK, et al
    Prognostic effect of microscopically negative but close resection margin in gastric cancer.
    Eur J Surg Oncol. 2024;50:108517.
    PubMed     Abstract available


  15. AAMIR N, Waqar SA
    Letter to the editor 'Staging laparoscopy with peritoneal lavage to identify peritoneal metastases and free intraperitoneal cancer cells in the management of locally advanced gastric cancer'.
    Eur J Surg Oncol. 2024;50:108466.
    PubMed    


  16. CHAI Y, Lin B, Zhong J, Wu X, et al
    Long-term outcomes of endoscopic therapy versus surgical resection for 2-5 cm gastric gastrointestinal stromal tumors: A population-based comparative study.
    Eur J Surg Oncol. 2024;50:108262.
    PubMed     Abstract available


    May 2024
  17. MANSOOR M, Ahmed M, Manzoor I
    "Shaping gastric cancer outcomes: Advancing diagnosis and treatment through staging laparoscopy in peritoneal Metastasis detection".
    Eur J Surg Oncol. 2024;50:108448.
    PubMed    


    April 2024
  18. ZHANG LK, Zheng HL, Zheng HH, Ma YB, et al
    Effects of tumor marker regression load score on long-term prognosis of gastric cancer patients undergoing radical surgery after neoadjuvant chemotherapy.
    Eur J Surg Oncol. 2024;50:108367.
    PubMed     Abstract available


  19. BELIA F, Kim KY, Agnes A, Park SH, et al
    Predicting peritoneal recurrence after radical gastrectomy for gastric cancer: Validation of a prediction model (PERI-Gastric 1 and PERI-Gastric 2) on a Korean database.
    Eur J Surg Oncol. 2024;50:108359.
    PubMed     Abstract available


  20. BHANDARE MS, Gundavda KK, Yelamanchi R, Chopde A, et al
    Impact of pCR after neoadjuvant chemotherapy and radical D2 dissection in locally advanced gastric cancers: Analysis of 1001 cases.
    Eur J Surg Oncol. 2024;50:108343.
    PubMed     Abstract available


  21. COSTA PMD, Antunes C, Lages P, Rodrigues J, et al
    Challenging the Dogma: Stage migration or negative lymph nodes, which of them is the main player on gastric cancer prognosis?
    Eur J Surg Oncol. 2024;50:108318.
    PubMed     Abstract available


  22. SHEEN AR, Saqib HWU
    "Harnessing AI for treatment optimization: Neoadjuvant chemotherapy in gastroesophageal cancer".
    Eur J Surg Oncol. 2024;50:108228.
    PubMed    


  23. KUHLEN M, Kunstreich M, Pape UF, Seitz G, et al
    Lymph node metastases are more frequent in paediatric appendiceal NET >/=1.5 cm but without impact on outcome - Data from the German MET studies.
    Eur J Surg Oncol. 2024;50:108051.
    PubMed     Abstract available


  24. VAN HOOTEGEM SJM, Chmelo J, van der Sluis PC, Lagarde SM, et al
    The yield of diagnostic laparoscopy with peritoneal lavage in gastric adenocarcinoma: A retrospective cohort study.
    Eur J Surg Oncol. 2024;50:108233.
    PubMed     Abstract available


  25. MAURER CA, Walensi M, Mattiello D, Kaser SA, et al
    Intraoperative esophageal washout reduces free intraluminal tumor cells during resection of carcinomas of the esophagus and cardia.
    Eur J Surg Oncol. 2024;50:108017.
    PubMed     Abstract available


    March 2024
  26. HUANG ZN, Zheng CY, Wu J, Tang YH, et al
    Textbook oncological outcomes and prognosis after curative gastrectomy in advanced gastric cancer: A multicenter study.
    Eur J Surg Oncol. 2024;50:108280.
    PubMed     Abstract available


  27. VAN DER SLUIS K, Guchelaar NAD, Triemstra L, Mathijssen RHJ, et al
    Staging laparoscopy in gastric cancer patients: From a Dutch nationwide Delphi consensus towards a standardized protocol.
    Eur J Surg Oncol. 2024;50:108278.
    PubMed     Abstract available


  28. HUANG B, Rampulla V, Ri M, Lindblad M, et al
    Staging laparoscopy with peritoneal lavage to identify peritoneal metastases and free intraperitoneal cancer cells in the management of locally advanced gastric cancer.
    Eur J Surg Oncol. 2024;50:108059.
    PubMed     Abstract available


  29. LIN X, Tan C, Wu W, Liang C, et al
    Evaluation of factors influencing long-term and textbook outcomes in laparoscopic gastrectomy.
    Eur J Surg Oncol. 2024;50:108002.
    PubMed     Abstract available


    February 2024
  30. NOOR Z, Gossage J, Evans O, Cuffe R, et al
    Unmet needs in survivorship: Increased anxiety post oesophago-gastric cancer surgery.
    Eur J Surg Oncol. 2024;50:108046.
    PubMed     Abstract available


  31. LI J, Chen X, Xu S, Wang Y, et al
    Predicting pathologic response to neoadjuvant chemotherapy in locally advanced gastric cancer: The establishment of a spectral CT-based nomogram from prospective datasets.
    Eur J Surg Oncol. 2024;50:108020.
    PubMed     Abstract available


  32. ZHENG HL, Wei LH, Xu BB, Zheng HH, et al
    Prognostic value of preoperative sarcopenia in gastric cancer: A 10-year follow-up study.
    Eur J Surg Oncol. 2024;50:108004.
    PubMed     Abstract available


    January 2024
  33. TAKI Y, Ito S, Mizusawa J, Yura M, et al
    Risk factors for abdominal surgical infectious complications after distal gastrectomy for gastric cancer: A post-hoc analysis of a randomized controlled trial (JCOG0912).
    Eur J Surg Oncol. 2024;50:107982.
    PubMed     Abstract available


    December 2023
  34. MIAO X, Guo Y, Chen Y, Xu X, et al
    Exploration of frailty trajectories and their associations with health outcomes in older gastric cancer survivors undergoing radical gastrectomy: A prospective longitudinal observation study.
    Eur J Surg Oncol. 2023;50:107934.
    PubMed     Abstract available


  35. YAO GL, Tao YJ, Fan YG
    Cutaneous metastasis from gastric cancer: Manifestation, diagnosis, treatment and prognosis.
    Eur J Surg Oncol. 2023;50:107939.
    PubMed     Abstract available


  36. MENG C, Cao S, Yu Q, Tian Y, et al
    Short- and long-term comparison of robotic versus laparoscopic gastrectomy for gastric cancer patients with BMI>/=30 kg/m(2): A propensity score matched analysis.
    Eur J Surg Oncol. 2023;50:107312.
    PubMed     Abstract available


  37. HOJO Y, Ishida Y, Tomita T, Kurahashi Y, et al
    Treatment strategy for successful conversion surgery in clinical stage IVB gastric cancer.
    Eur J Surg Oncol. 2023;50:107314.
    PubMed     Abstract available


  38. TRIEMSTRA L, de Jongh C, Tedone F, Brosens LAA, et al
    The Comprehensive Complication Index versus Clavien-Dindo grading after laparoscopic and open D2-gastrectomy in the multicenter randomized LOGICA-trial.
    Eur J Surg Oncol. 2023;49:107095.
    PubMed     Abstract available


    November 2023
  39. MINISTRINI S, Bencivenga M, Filippini F, Mura G, et al
    A pragmatic approach improves the clinical management of stage IV gastric cancer: Comparison between the Meta-Gastro results and the GIRCG's retrospective series.
    Eur J Surg Oncol. 2023;50:107275.
    PubMed     Abstract available


  40. HOLMEN A, Jebril W, Ida S, Agustsson T, et al
    Effects of neoadjuvant therapy on health-related quality of life for patients with gastroesophageal cancer.
    Eur J Surg Oncol. 2023;49:107008.
    PubMed     Abstract available


  41. KANG MK, Kim J, Choi JH, Choe HN, et al
    Can prospective monitoring improve complication rates after gastrectomy? Experience of Billroth I reconstruction at a high-volume tertiary center.
    Eur J Surg Oncol. 2023;49:106985.
    PubMed     Abstract available


  42. HUANG ZN, Huang YQ, Hong QQ, Zhang P, et al
    Long-term prognostic benefit of adjuvant chemotherapy for patients with hepatoid adenocarcinoma of the stomach after radical resection: A national multicenter study.
    Eur J Surg Oncol. 2023;49:106975.
    PubMed     Abstract available


  43. SALAVATIZADEH M, Soltanieh S, Radkhah N, Ataei Kachouei AH, et al
    The association between skeletal muscle mass index (SMI) and survival after gastrectomy: A systematic review and meta-analysis of cohort studies.
    Eur J Surg Oncol. 2023;49:106980.
    PubMed     Abstract available


    October 2023
  44. ZHANG J, Cao X, Dai N, Zhu S, et al
    Efficacy analysis of endoscopic treatment of giant gastric gastrointestinal stromal tumors (>/=5 cm).
    Eur J Surg Oncol. 2023;49:106955.
    PubMed     Abstract available


  45. WITHEY SJ, Owczarczyk K, Grzeda MT, Yip C, et al
    Association of dynamic contrast-enhanced MRI and (18)F-Fluorodeoxyglucose PET/CT parameters with neoadjuvant therapy response and survival in esophagogastric cancer.
    Eur J Surg Oncol. 2023;49:106934.
    PubMed     Abstract available


    September 2023
  46. ZHENG CY, Wu J, Chen CS, Huang ZN, et al
    A scoring model for predicting early recurrence of gastric cancer with normal preoperative tumor markers: A multicenter study.
    Eur J Surg Oncol. 2023;49:107094.
    PubMed     Abstract available


  47. ZHOU M, Zhong G, Sun H, Zhu Q, et al
    Risk factors for postoperative pancreatic fistula (POPF) in gastric cancer patients: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2023;49:107092.
    PubMed     Abstract available


  48. REIS ME, Ulusahin M, Cekic AB, Usta MA, et al
    Does surgeon specialization add value to surgeon volume in gastric cancer surgery?
    Eur J Surg Oncol. 2023;49:107091.
    PubMed     Abstract available


  49. IKEGAME K, Hatakeyama K, Terashima M, Sugino T, et al
    Molecular profiling of gastric neuroendocrine carcinomas.
    Eur J Surg Oncol. 2023;49:106987.
    PubMed     Abstract available


  50. LUIJTEN JCHBM, Vissers PAJ, Geerts J, Lemmens VEP, et al
    Hospital practice variation in the proportion of patients with esophagogastric cancer discussed during an expert multidisciplinary team meeting.
    Eur J Surg Oncol. 2023;49:106880.
    PubMed     Abstract available


  51. LIN X, Tan C, Li Z, Wu W, et al
    Long-term oncologic and surgical outcomes of robotic and laparoscopic gastrectomy for Siewert II/III esophagogastric junction carcinoma: A propensity score-matched retrospective cohort study.
    Eur J Surg Oncol. 2023;49:106898.
    PubMed     Abstract available


  52. FUNK-DEBLEDS P, Rossi J, Bernard L, Galan A, et al
    Post-operative weight loss affects 3-year survival in patients with gastric adenocarcinoma after gastrectomy and hyperthermic intraperitoneal chemotherapy.
    Eur J Surg Oncol. 2023;49:106895.
    PubMed     Abstract available


    August 2023
  53. DE JONGH C, Triemstra L, van der Veen A, Brosens LA, et al
    Surgical quality and prospective quality control of the D2-gastrectomy for gastric cancer in the multicenter randomized LOGICA-trial.
    Eur J Surg Oncol. 2023;49:107018.
    PubMed     Abstract available


    June 2023
  54. BIONDI A, Lorenzon L, Santoro G, Agnes A, et al
    Profiling complete regression after pre-operative therapy in gastric cancer patients using clinical and pathological data.
    Eur J Surg Oncol. 2023 Jun 30:S0748-7983(23)00561.
    PubMed     Abstract available


    March 2023
  55. HERRERA-KOK JH, Parmar C, Bangash AH, Samadov E, et al
    Global impact of COVID-19 pandemic on gastric cancer patients.
    Eur J Surg Oncol. 2023 Mar 2:S0748-7983(23)00170.
    PubMed    


    January 2023
  56. JANG A, Jeong O
    The impact of the 30-day postoperative complications on the quality of life following gastrectomy for gastric carcinoma: A prospective study.
    Eur J Surg Oncol. 2023 Jan 18:S0748-7983(23)00083.
    PubMed     Abstract available


  57. ZHENG HL, Lin J, Shen LL, Yang HB, et al
    The GLIM criteria as an effective tool for survival prediction in gastric cancer patients.
    Eur J Surg Oncol. 2023 Jan 12:S0748-7983(23)00031.
    PubMed     Abstract available


  58. KROESE TE, van Rossum PSN, Nilsson M, Lordick F, et al
    Study protocol for the OligoMetastatic Esophagogastric Cancer (OMEC) project: A multidisciplinary European consensus project on the definition and treatment for oligometastatic esophagogastric cancer.
    Eur J Surg Oncol. 2023;49:21-28.
    PubMed     Abstract available


  59. LEIJONMARCK W, Asplund J, Markar SR, Mattsson F, et al
    Weekday of gastrectomy and long-term survival in gastric adenocarcinoma.
    Eur J Surg Oncol. 2023;49:83-88.
    PubMed     Abstract available


  60. KUMAZU Y, Hasegawa S, Hayashi T, Yamada T, et al
    Should the splenic hilar lymph node be dissected for the management of adenocarcinoma of the esophagogastric junction?
    Eur J Surg Oncol. 2023;49:76-82.
    PubMed     Abstract available


    December 2022
  61. KUBO N, Cho H, Lee D, Yang H, et al
    Risk prediction model of peritoneal seeding in advanced gastric cancer: A decision tool for diagnostic laparoscopy.
    Eur J Surg Oncol. 2022 Dec 26:S0748-7983(22)01359.
    PubMed     Abstract available


  62. XU R, Zhang Y, Zhao J, Chen K, et al
    Prognostic value of tumor deposits in lymph node-negative gastric cancer: A propensity score matching study.
    Eur J Surg Oncol. 2022 Dec 14:S0748-7983(22)01350.
    PubMed     Abstract available


    November 2022
  63. TORIUMI T, Terashima M, Mizusawa J, Sato Y, et al
    Recurrence patterns after curative gastrectomy for pStage II/III gastric cancer: Exploratory analysis of the randomized controlled JCOG1001 trial.
    Eur J Surg Oncol. 2022 Nov 16:S0748-7983(22)00821.
    PubMed     Abstract available


    September 2022
  64. JERICO C, Puertolas N, Osorio J, Miranda C, et al
    Cost analysis of a patient blood management program for patients undergoing gastric cancer surgery.
    Eur J Surg Oncol. 2022 Sep 20. pii: S0748-7983(22)00658.
    PubMed     Abstract available


  65. CHEN WZ, Yu DY, Zhang XZ, Zhang FM, et al
    Comparison of laparoscopic and open radical gastrectomy for gastric cancer patients with GLIM-defined malnutrition.
    Eur J Surg Oncol. 2022 Sep 17. pii: S0748-7983(22)00676.
    PubMed     Abstract available


  66. NAGASAWA S, Sato T, Morita J, Kondo H, et al
    Solitary living worsens the continuation of adjuvant chemotherapy for gastric cancer.
    Eur J Surg Oncol. 2022 Sep 9. pii: S0748-7983(22)00654.
    PubMed     Abstract available


  67. NISHIO S, Matsuo K, Nasu H, Murotani K, et al
    Analysis of postoperative adjuvant therapy in 102 patients with gastric-type mucinous carcinoma of the uterine cervix: A multi-institutional study.
    Eur J Surg Oncol. 2022;48:2039-2044.
    PubMed     Abstract available


  68. DIJKSTERHUIS WPM, Kroese TE, Verhoeven RHA, van Rossum PSN, et al
    A population-based study on treatment and outcomes in patients with gastric adenocarcinoma diagnosed with distant interval metastases.
    Eur J Surg Oncol. 2022;48:1964-1971.
    PubMed     Abstract available


    August 2022
  69. LI Y, Chen X, Ma X, Lu X, et al
    Computed tomography in the size measurement of gastric gastrointestinal stromal tumors: Implication to risk stratification and "wait-and-see" tactics.
    Eur J Surg Oncol. 2022;48:1739-1745.
    PubMed     Abstract available


    July 2022
  70. CHEN QY, Que SJ, Chen JY, Qing-Zhong, et al
    Development and validation of metabolic scoring to individually predict prognosis and monitor recurrence early in gastric cancer: A large-sample analysis.
    Eur J Surg Oncol. 2022 Jul 14. pii: S0748-7983(22)00521.
    PubMed     Abstract available


  71. HAJJAR R, Mercier F, Passot G, Pasquer A, et al
    Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for small bowel neuroendocrine tumors with peritoneal metastasis.
    Eur J Surg Oncol. 2022;48:1626-1630.
    PubMed     Abstract available


    June 2022
  72. WANG L, Lv P, Xue Z, Chen L, et al
    Novel CT based clinical nomogram comparable to radiomics model for identification of occult peritoneal metastasis in advanced gastric cancer.
    Eur J Surg Oncol. 2022 Jun 30. pii: S0748-7983(22)00539.
    PubMed     Abstract available


  73. CHEN Y, Sun R, Liu W
    Impact of a previous cancer history on the overall survival of patients with primary gastric cancer: A SEER population-based study.
    Eur J Surg Oncol. 2022 Jun 20. pii: S0748-7983(22)00524.
    PubMed     Abstract available


  74. CHEN JY, Lin GT, Chen QY, Zhong Q, et al
    Textbook outcome, chemotherapy compliance, and prognosis after radical gastrectomy for gastric cancer: A large sample analysis.
    Eur J Surg Oncol. 2022 Jun 9. pii: S0748-7983(22)00475.
    PubMed     Abstract available


  75. SONG JH, Shin HJ, Lee S, Park SH, et al
    No detrimental effect of perioperative blood transfusion on recurrence in 2905 stage II/III gastric cancer patients: A propensity-score matching analysis.
    Eur J Surg Oncol. 2022 Jun 1. pii: S0748-7983(22)00476.
    PubMed     Abstract available


    May 2022
  76. JEONG SA, Yoo MW, Lee IS, Gong CS, et al
    Comparing surgical and oncologic outcomes between laparoscopic gastrectomy and open gastrectomy in advanced gastric cancer with serosal invasion: A retrospective study with propensity score matching.
    Eur J Surg Oncol. 2022 May 23. pii: S0748-7983(22)00464.
    PubMed     Abstract available


  77. ARGILLANDER TE, Festen S, van der Zaag-Loonen HJ, de Graeff P, et al
    Outcomes of surgical treatment of non-metastatic gastric cancer in patients aged 70 and older: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2022 May 16. pii: S0748-7983(22)00428.
    PubMed     Abstract available


  78. EVANS RP, Kamarajah SK, Kunene V, Zardo D, et al
    Impact of neoadjuvant chemotherapy on nodal regression and survival in oesophageal adenocarcinoma.
    Eur J Surg Oncol. 2022;48:1001-1010.
    PubMed     Abstract available


  79. SPOLVERATO G, Azzolina D, Paro A, Lorenzoni G, et al
    Dynamic Prediction of Survival after Curative Resection of Gastric Adenocarcinoma: A landmarking-based analysis.
    Eur J Surg Oncol. 2022;48:1025-1032.
    PubMed     Abstract available


    April 2022
  80. LEE TY, Hsu CH, Fan HL, Liao GS, et al
    Prophylactic hyperthermic intraperitoneal chemotherapy for patients with clinical T4 gastric cancer.
    Eur J Surg Oncol. 2022 Apr 27. pii: S0748-7983(22)00413.
    PubMed     Abstract available


    March 2022
  81. HAYASHI T, Yoshikawa T
    Reply to: Letter to the Editor "Suprapancreatic nodal dissection should not be uniformly selected in additional gastrectomy for the patients diagnosed as pT1b gastric cancer by endoscopic resection".
    Eur J Surg Oncol. 2022 Mar 25. pii: S0748-7983(22)00155.
    PubMed    


  82. MATSUI R, Rifu K, Watanabe J, Inaki N, et al
    Letter to the Editor "Suprapancreatic nodal dissection should not be uniformly selected in additional gastrectomy for patients diagnosed with pT1b gastric cancer via endoscopic resection".
    Eur J Surg Oncol. 2022 Mar 19. pii: S0748-7983(22)00132.
    PubMed    


  83. DENG H, Qin X
    Comment on Granieri et al. "Prognostic impact of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in gastric cancer patients: A meta-analysis of randomized controlled trials".
    Eur J Surg Oncol. 2022 Mar 12. pii: S0748-7983(22)00122.
    PubMed    


  84. LU J, Wu D, Chen S, Huang JB, et al
    A novel hematological classifier predicting chemotherapy benefit and recurrence hazard for locally advanced gastric cancer A multicenter IPTW analysis.
    Eur J Surg Oncol. 2022 Mar 5. pii: S0748-7983(22)00044.
    PubMed     Abstract available


  85. KAMIYA A, Yoshikawa T, Sakon R, Ishizu K, et al
    Optimal surgery and lymph node metastasis of duodenal bulbar neuroendocrine neoplasms.
    Eur J Surg Oncol. 2022;48:597-603.
    PubMed     Abstract available


  86. VAN DER WIELEN N, Daams F, Rosati R, Parise P, et al
    Health related quality of life following open versus minimally invasive total gastrectomy for cancer: Results from a randomized clinical trial.
    Eur J Surg Oncol. 2022;48:553-560.
    PubMed     Abstract available


    February 2022
  87. QIU WW, Chen QY, Zheng WZ, He QC, et al
    Postoperative follow-up for gastric cancer needs to be individualized according to age, tumour recurrence pattern, and recurrence time.
    Eur J Surg Oncol. 2022 Feb 25. pii: S0748-7983(22)00119.
    PubMed     Abstract available


  88. AMROUN K, Scholer V, Djerada Z, Renard Y, et al
    Inflammatory biomarkers to predict postoperative infectious complications after cytoreductive surgery and HIPEC for peritoneal carcinomatosis.
    Eur J Surg Oncol. 2022;48:455-461.
    PubMed     Abstract available


  89. CHOI M, Ishizawa S, Kraemer D, Sasson A, et al
    Perioperative chemotherapy versus adjuvant chemotherapy strategies in resectable gastric and gastroesophageal cancer: A Markov decision analysis.
    Eur J Surg Oncol. 2022;48:403-410.
    PubMed     Abstract available


  90. OH SE, Lee GH, An JY, Lee JH, et al
    Comparison of transabdominal and transthoracic surgical approaches in the treatment of Siewert type II esophagogastric junction cancers: A propensity score-matching analysis.
    Eur J Surg Oncol. 2022;48:370-376.
    PubMed     Abstract available


  91. LUIJTEN JCHBM, Nieuwenhuijzen GAP, Sosef MN, de Hingh IHJT, et al
    Impact of nationwide centralization of oesophageal, gastric, and pancreatic surgery on travel distance and experienced burden in the Netherlands.
    Eur J Surg Oncol. 2022;48:348-355.
    PubMed     Abstract available


  92. HAYASHI T, Yoshikawa T, Ishizu K, Tsutsui M, et al
    Suprapancreatic nodal dissection should not be uniformly selected in additional gastrectomy for the patients who diagnosed as pT1b gastric cancer by endoscopic resection.
    Eur J Surg Oncol. 2022 Feb 1. pii: S0748-7983(22)00072.
    PubMed     Abstract available


    January 2022
  93. SOLAINI L, Bencivenga M, D'ignazio A, Milone M, et al
    Which gastric cancer patients could benefit from staging laparoscopy? A GIRCG multicenter cohort study.
    Eur J Surg Oncol. 2022 Jan 22. pii: S0748-7983(22)00046.
    PubMed     Abstract available


  94. TERASHIMA M, Sano T, Mizusawa J, Umemura K, et al
    Prediction of the peritoneal recurrence via the macroscopic diagnosis of the serosal invasion in patients with gastric cancer: Supplementary analysis of JCOG0110.
    Eur J Surg Oncol. 2022 Jan 19. pii: S0748-7983(22)00040.
    PubMed     Abstract available


  95. YASUFUKU I, Ohashi M, Makuuchi R, Hayami M, et al
    High prevalence of peritoneal metastasis in gastric cancer presenting gastric outlet obstruction: A new candidate for consecutive diagnostic staging laparoscopy and laparoscopic gastrojejunostomy.
    Eur J Surg Oncol. 2022 Jan 11. pii: S0748-7983(22)00012.
    PubMed     Abstract available


  96. TAKEBAYASHI K, Murata S, Kodama H, Kaida S, et al
    Long-term prognosis of patients with cancer-related genes detected in postoperative peritoneal washings obtained during curative gastrectomy.
    Eur J Surg Oncol. 2022;48:177-182.
    PubMed     Abstract available


    December 2021
  97. CERO MD, Rodriguez-Santiago J, Miro M, Castro S, et al
    Evaluation of data quality in the Spanish EURECCA Esophagogastric Cancer Registry.
    Eur J Surg Oncol. 2021;47:3081-3087.
    PubMed     Abstract available


    November 2021
  98. QIU Y, Zhang X, Deng X, Zhang R, et al
    Circulating tumor cell-associated white blood cell cluster is associated with poor survival of patients with gastric cancer following radical gastrectomy.
    Eur J Surg Oncol. 2021 Nov 21. pii: S0748-7983(21)00924.
    PubMed     Abstract available


  99. HUANG SF, Chen TC, Hsu JT, Tsai CY, et al
    Lymph node micrometastasis of poorly differentiated node-negative gastric cancer risks a worse-than-expected survival outcome under standard management algorithm.
    Eur J Surg Oncol. 2021 Nov 19. pii: S0748-7983(21)00926.
    PubMed     Abstract available


  100. DAL CERO M, Roman M, Grande L, Yarnoz C, et al
    Textbook outcome and survival after gastric cancer resection with curative intent: A population-based analysis.
    Eur J Surg Oncol. 2021 Nov 2. pii: S0748-7983(21)00775.
    PubMed     Abstract available


    September 2021
  101. ROVIELLO F, Marano L, Ambrosio MR, Resca L, et al
    Signet ring cell percentage in poorly cohesive gastric cancer patients: A potential novel predictor of survival.
    Eur J Surg Oncol. 2021 Sep 7. pii: S0748-7983(21)00726.
    PubMed     Abstract available


    August 2021
  102. JAVANBAKHT M, Mashayekhi A, Branagan-Harris M, Horvath P, et al
    Cost-effectiveness analysis of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with gastric cancer and peritoneal metastasis.
    Eur J Surg Oncol. 2021 Aug 28. pii: S0748-7983(21)00696.
    PubMed     Abstract available


  103. PARK JH, Berlth F, Wang C, Wang S, et al
    Mapping of the perigastric lymphatic network using indocyanine green fluorescence imaging and tissue marking dye in clinically advanced gastric cancer.
    Eur J Surg Oncol. 2021 Aug 27. pii: S0748-7983(21)00701.
    PubMed     Abstract available


  104. ZHANG FM, Zhang XZ, Zhu GL, Lv LQ, et al
    Impact of sarcopenia on clinical outcomes of patients with stage I gastric cancer after radical gastrectomy: A prospective cohort study.
    Eur J Surg Oncol. 2021 Aug 17. pii: S0748-7983(21)00693.
    PubMed     Abstract available


  105. SEDLAK K, Rawicz-Pruszynski K, Mlak R, Geca K, et al
    Union is strength: Textbook outcome with perioperative chemotherapy compliance decreases the risk of death in advanced gastric cancer patients.
    Eur J Surg Oncol. 2021 Aug 11. pii: S0748-7983(21)00674.
    PubMed     Abstract available


  106. RI M, Yamashita H, Gonoi W, Okumura Y, et al
    Identifying multiple swollen lymph nodes on preoperative computed tomography is associated with poor prognosis along with pathological extensive nodal metastasis in locally advanced gastric cancer.
    Eur J Surg Oncol. 2021 Aug 10. pii: S0748-7983(21)00687.
    PubMed     Abstract available


  107. BORGSTEIN ABJ, Keywani K, Eshuis WJ, van Berge Henegouwen MI, et al
    Staging laparoscopy in patients with advanced gastric cancer: A single center cohort study.
    Eur J Surg Oncol. 2021 Aug 8. pii: S0748-7983(21)00672.
    PubMed     Abstract available


  108. CHALLINE A, Voron T, Dousset B, Creavin B, et al
    Postoperative outcomes after laparoscopic or open gastrectomy. A national cohort study of 10,343 patients.
    Eur J Surg Oncol. 2021;47:1985-1995.
    PubMed     Abstract available


  109. ZOU HB, Yan XL, Dong WX, Yu DY, et al
    Sarcopenia is a predictive factor of poor quality of life and prognosis in patients after radical gastrectomy.
    Eur J Surg Oncol. 2021;47:1976-1984.
    PubMed     Abstract available


  110. YAMAGATA Y, Yoshikawa T, Ishizu K, Kamiya A, et al
    Is lymph node dissection for neuroendocrine carcinoma of the stomach effective as it is for adenocarcinoma?
    Eur J Surg Oncol. 2021;47:2004-2009.
    PubMed     Abstract available


  111. HAYASHI M, Fujita T, Matsushita H
    Prognostic value of tumor regression grade following the administration of neoadjuvant chemotherapy as treatment for gastric/gastroesophageal adenocarcinoma: A meta-analysis of 14 published studies.
    Eur J Surg Oncol. 2021;47:1996-2003.
    PubMed     Abstract available


    July 2021
  112. CHEN Y, Yuan F, Wang L, Li E, et al
    Evaluation of dual-energy CT derived radiomics signatures in predicting outcomes in patients with advanced gastric cancer after neoadjuvant chemotherapy.
    Eur J Surg Oncol. 2021 Jul 20. pii: S0748-7983(21)00635.
    PubMed     Abstract available


  113. WADA T, Yoshikawa T, Sekine S, Kamiya A, et al
    Pathological complete response at the para-aortic nodes as a possible surrogate endpoint in gastric cancer surgery with para-aortic node dissection after neoadjuvant chemotherapy.
    Eur J Surg Oncol. 2021 Jul 17. pii: S0748-7983(21)00637.
    PubMed     Abstract available


  114. KACMAZ E, Slooter MD, Nieveen van Dijkum EJM, Tanis PJ, et al
    Fluorescence angiography guided resection of small bowel neuroendocrine neoplasms with mesenteric lymph node metastases.
    Eur J Surg Oncol. 2021;47:1611-1615.
    PubMed     Abstract available


    June 2021
  115. ROH CK, Hyung WJ
    Reply to: Letter to Roh CK et al. 'Incidence and treatment outcomes of leakage after gastrectomy for gastric cancer: Experience of 14,075 patients from a large volume centre'.
    Eur J Surg Oncol. 2021 Jun 9. pii: S0748-7983(21)00543.
    PubMed    


  116. CARBONI F, Valle M
    Letter to Roh CK et al. 'Incidence and treatment outcomes of leakage after gastrectomy for gastric cancer: Experience of 14,075 patients from a large volume centre'.
    Eur J Surg Oncol. 2021 Jun 5. pii: S0748-7983(21)00544.
    PubMed    


  117. BARCOT O, Boric M, Cavar M, Poropat G, et al
    Predictive value of abdominal drain amylase for postoperative pancreatic fistula following gastric resection: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2021;47:1244-1251.
    PubMed     Abstract available


    May 2021
  118. GRANIERI S, Bonomi A, Frassini S, Chierici AP, et al
    Prognostic impact of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in gastric cancer patients: A meta-analysis of randomized controlled trials.
    Eur J Surg Oncol. 2021 May 11. pii: S0748-7983(21)00492.
    PubMed     Abstract available


    April 2021
  119. LIN YC, Lin G, Yeh TS
    Visceral-to-subcutaneous fat ratio independently predicts the prognosis of locally advanced gastric cancer----- highlighting the role of adiponectin receptors and PPARalpha, beta/ delta, .
    Eur J Surg Oncol. 2021 Apr 26. pii: S0748-7983(21)00456.
    PubMed     Abstract available


  120. OH YJ, Kim DH, Han WH, Eom BW, et al
    Risk factors for lymph node metastasis in early gastric cancer without lymphatic invasion after endoscopic submucosal dissection.
    Eur J Surg Oncol. 2021 Apr 26. pii: S0748-7983(21)00457.
    PubMed     Abstract available


  121. KANO Y, Ohashi M, Muneoka Y, Takahari D, et al
    Different risk factors for three major recurrence patterns of pathological stage II or III gastric cancer patients who completed adjuvant S-1 monotherapy.
    Eur J Surg Oncol. 2021 Apr 21. pii: S0748-7983(21)00446.
    PubMed     Abstract available


  122. FAIZ Z, Hayashi T, Yoshikawa T
    Lymph node dissection for gastric cancer: Establishment of D2 and the current position of splenectomy in Europe and Japan.
    Eur J Surg Oncol. 2021 Apr 21. pii: S0748-7983(21)00447.
    PubMed     Abstract available


  123. KIM DG, Seo WJ, Cho M, Kim YM, et al
    Perioperative, short-, and long-term outcomes of gastric cancer surgery: Propensity score-matched analysis of patients with or without prior solid organ transplantation.
    Eur J Surg Oncol. 2021 Apr 21. pii: S0748-7983(21)00445.
    PubMed     Abstract available


  124. CHEN XD, He FQ, Liao MS, Chen M, et al
    Laparoscopic versus open transhiatal approach for adenocarcinoma of the esophagogastric junction: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2021;47:778-788.
    PubMed     Abstract available


    March 2021
  125. BOLGER JC, Al Azzawi M, Whooley J, Bolger EM, et al
    Surgery by a minimally invasive approach is associated with improved textbook outcomes in oesophageal and gastric cancer.
    Eur J Surg Oncol. 2021 Mar 17. pii: S0748-7983(21)00381.
    PubMed     Abstract available


  126. LEE KG, Shin CI, Kim SG, Choi J, et al
    Can endoscopic ultrasonography (EUS) improve the accuracy of clinical T staging by computed tomography (CT) for gastric cancer?
    Eur J Surg Oncol. 2021 Mar 10. pii: S0748-7983(21)00125.
    PubMed     Abstract available


  127. HUANG DD, Yu DY, Song HN, Wang WB, et al
    The relationship between the GLIM-defined malnutrition, body composition and functional parameters, and clinical outcomes in elderly patients undergoing radical gastrectomy for gastric cancer.
    Eur J Surg Oncol. 2021 Mar 6. pii: S0748-7983(21)00126.
    PubMed     Abstract available


    February 2021
  128. ROH CK, Choi S, Seo WJ, Cho M, et al
    Incidence and treatment outcomes of leakage after gastrectomy for gastric cancer: Experience of 14,075 patients from a large volume centre.
    Eur J Surg Oncol. 2021 Feb 25. pii: S0748-7983(21)00104.
    PubMed     Abstract available


  129. MURNANE LC, Forsyth AK, Koukounaras J, Pilgrim CH, et al
    Myosteatosis predicts higher complications and reduced overall survival following radical oesophageal and gastric cancer surgery.
    Eur J Surg Oncol. 2021 Feb 19. pii: S0748-7983(21)00099.
    PubMed     Abstract available


  130. WEN L, Yu K, Lu H, Zhong G, et al
    Impact of prior cancer history on survival of patients with gastric cancer.
    Eur J Surg Oncol. 2021 Feb 11. pii: S0748-7983(21)00090.
    PubMed     Abstract available


  131. XING J, Wang Y, Shan F, Li S, et al
    Comparison of totally laparoscopic and laparoscopic assisted gastrectomy after neoadjuvant chemotherapy in locally advanced gastric cancer.
    Eur J Surg Oncol. 2021 Feb 6. pii: S0748-7983(21)00085.
    PubMed     Abstract available


    January 2021
  132. KOSEKI Y, Hikage M, Fujiya K, Kamiya S, et al
    Utility of a modified age-adjusted Charlson Comorbidity Index in predicting cause-specific survival among patients with gastric cancer.
    Eur J Surg Oncol. 2021 Jan 30. pii: S0748-7983(21)00056.
    PubMed     Abstract available


    December 2020
  133. JI ZH, Yu Y, Liu G, Zhang YB, et al
    Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: A single-center retrospective analysis of 125 patients.
    Eur J Surg Oncol. 2020 Dec 1. pii: S0748-7983(20)31035.
    PubMed     Abstract available


  134. KOEMANS WJ, van Sandick JW, Huitema ADR
    Reply to: Comments on "Systemic exposure of oxaliplatin and docetaxel in gastric patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy".
    Eur J Surg Oncol. 2020;46:2343.
    PubMed    


    November 2020
  135. OSORIO J, Jerico C, Miranda C, Santamaria M, et al
    Improved postoperative outcomes and reduced transfusion rates after implementation of a Patient Blood Management program in gastric cancer surgery.
    Eur J Surg Oncol. 2020 Nov 27. pii: S0748-7983(20)31025.
    PubMed     Abstract available


  136. KINOSHITA T, Sato R, Akimoto E, Yoshida M, et al
    Can laparoscopic spleen-preserving splenic hilar lymph node dissection replace prophylactic splenectomy for proximal advanced gastric cancers that invade the greater curvature?
    Eur J Surg Oncol. 2020 Nov 26. pii: S0748-7983(20)31029.
    PubMed     Abstract available


  137. WANG L, Gong J, Huang X, Lin G, et al
    CT-based radiomics nomogram for preoperative prediction of No.10 lymph nodes metastasis in advanced proximal gastric cancer.
    Eur J Surg Oncol. 2020 Nov 24. pii: S0748-7983(20)31028.
    PubMed     Abstract available


  138. BORGSTEIN ABJ, van Berge Henegouwen MI, Lameris W, Eshuis WJ, et al
    Staging laparoscopy in gastric cancer surgery. A population-based cohort study in patients undergoing gastrectomy with curative intent.
    Eur J Surg Oncol. 2020 Nov 17. pii: S0748-7983(20)30903.
    PubMed     Abstract available


    October 2020
  139. NISHIWAKI N, Irino T, Fujiya K, Kamiya S, et al
    Extra-nodal metastasis should be classified separately from lymph node metastasis in gastric cancer.
    Eur J Surg Oncol. 2020 Oct 23. pii: S0748-7983(20)30860.
    PubMed     Abstract available


  140. GERTSEN EC, Brenkman HJF, Brosens LAA, Luijten JCHBM, et al
    Refraining from resection in patients with potentially curable gastric carcinoma.
    Eur J Surg Oncol. 2020 Oct 22. pii: S0748-7983(20)30862.
    PubMed     Abstract available


  141. BENCIVENGA M, Torroni L, Verlato G, Mengardo V, et al
    Lymphadenectomy for gastric cancer at European specialist centres.
    Eur J Surg Oncol. 2020 Oct 15. pii: S0748-7983(20)30845.
    PubMed     Abstract available


  142. BRANDL A, Yonemura Y, Glehen O, Sugarbaker P, et al
    Long term survival in patients with peritoneal metastasised gastric cancer treated with cytoreductive surgery and HIPEC: A multi-institutional cohort from PSOGI.
    Eur J Surg Oncol. 2020 Oct 14. pii: S0748-7983(20)30839.
    PubMed     Abstract available


  143. ZHANG Z, Cheng S, Gong J, Lu M, et al
    Efficacy and safety of neoadjuvant immunotherapy in patients with microsatellite instability-high gastrointestinal malignancies: A case series.
    Eur J Surg Oncol. 2020;46.
    PubMed     Abstract available


  144. REN C, Xu RH
    The drug treatment research of gastrointestinal cancer in China.
    Eur J Surg Oncol. 2020;46.
    PubMed     Abstract available


    August 2020
  145. WEINDELMAYER J, Mengardo V, Veltri A, Torroni L, et al
    Should we still use prophylactic drain in gastrectomy for cancer? A systematic review and meta-analysis.
    Eur J Surg Oncol. 2020;46:1396-1403.
    PubMed     Abstract available


  146. DEFTEREOS I, Kiss N, Isenring E, Carter VM, et al
    A systematic review of the effect of preoperative nutrition support on nutritional status and treatment outcomes in upper gastrointestinal cancer resection.
    Eur J Surg Oncol. 2020;46:1423-1434.
    PubMed     Abstract available


    June 2020
  147. FUJIYA K, Ohshima K, Kitagawa Y, Hatakeyama K, et al
    Aberrant expression of Wnt/beta-catenin signaling pathway genes in aggressive malignant gastric gastrointestinal stromal tumors.
    Eur J Surg Oncol. 2020;46:1080-1087.
    PubMed     Abstract available


    April 2020
  148. ARCHID R, Zieker D, Weinreich FJ, Hones F, et al
    shRNA-mediated inhibition of PhosphoGlycerate Kinase 1 (PGK1) enhances cytotoxicity of intraperitoneal chemotherapy in peritoneal metastasis of gastric origin.
    Eur J Surg Oncol. 2020;46.
    PubMed     Abstract available


  149. WANG C, Gao Z, Shen K, Cao J, et al
    Safety and efficiency of endoscopic resection versus laparoscopic resection in gastric gastrointestinal stromal tumours: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2020;46.
    PubMed     Abstract available


  150. BHATT A, Yonemura Y, Mehta S, Benzerdjeb N, et al
    Target region resection in patients undergoing cytoreductive surgery for peritoneal metastases-is it necessary in absence of visible disease?
    Eur J Surg Oncol. 2020;46.
    PubMed     Abstract available


  151. SOMASHEKHAR SP, Yethadka R, Kumar C R, Ashwin KR, et al
    Toxicity profile of chemotherapy agents used in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies.
    Eur J Surg Oncol. 2020;46.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.